Institute of Medicine (United States)

Institute of Medicine (United States)
Name	Institute of Medicine
Formation	1970
Predecessor	Board on Health Care Services
Successor	National Academy of Medicine
Type	Nonprofit
Headquarters	Washington, D.C.
Parent organization	National Academies of Sciences, Engineering, and Medicine

Institute of Medicine (United States) was a nonprofit American organization established in 1970 to provide independent, evidence-based advice on health and medical policy to policymakers, researchers, and the public. It operated under the umbrella of the National Academies of Sciences, Engineering, and Medicine and produced influential reports that shaped decisions by the United States Congress, Centers for Disease Control and Prevention, Food and Drug Administration, and other agencies. The institute's work intersected with major figures and institutions in medicine such as Francis Collins, Anthony Fauci, Donald Henderson, and organizations like the World Health Organization, American Medical Association, and Robert Wood Johnson Foundation.

History

The origins trace to the reorganization of the National Academy of Sciences and the establishment of advisory committees in the late 1960s, with formal creation in 1970 under charter by the National Research Council and patronage linked to federal initiatives of the Richard Nixon administration. Early leadership included prominent physicians associated with Johns Hopkins University, Harvard Medical School, and Mayo Clinic, who responded to public debates exemplified by episodes such as the Tuskegee syphilis experiment revelations and the rise of bioethics after events like the Karen Ann Quinlan case. Throughout the 1970s and 1980s the institute convened panels on topics ranging from healthcare reform proposals debated by the United States Senate and the Jimmy Carter administration to responses to emerging threats highlighted by the HIV/AIDS epidemic and international outbreaks managed by Centers for Disease Control and Prevention collaboration.

Organization and governance

The institute functioned as a unit within the National Academies, overseen by a governing council drawn from leaders affiliated with institutions such as Columbia University, Stanford University, University of California, San Francisco, Yale University, and University of Pennsylvania. Committees and study panels were staffed by experts from organizations including American Public Health Association, Association of American Medical Colleges, Kaiser Permanente, and the Bill & Melinda Gates Foundation. Funding came from a mix of federal agencies like the National Institutes of Health, private foundations such as the Robert Wood Johnson Foundation, and corporate sponsors including Pfizer and Johnson & Johnson, with conflict-of-interest policies influenced by precedents set by Institute of Medicine reports and recommendations adopted by the Office of Management and Budget.

Function and activities

The institute convened expert consensus studies, issued consensus reports, and organized workshops that mobilized specialists from Centers for Disease Control and Prevention, World Health Organization, American Cancer Society, and the American Heart Association. Activities included producing standards for clinical practice influenced by work at Mayo Clinic and Cleveland Clinic, advising on biomedical research priorities aligned with the National Institutes of Health roadmap, and shaping public health preparedness strategies used by the Department of Homeland Security and Federal Emergency Management Agency. The institute's role extended to ethical guidance referencing cases adjudicated in courts such as the Supreme Court of the United States and to education efforts linked to medical schools at Harvard Medical School and University of California, San Francisco.

Major reports and impact

High-profile reports affected policy on topics including patient safety, leading to the 1999 report that popularized the phrase "To Err Is Human" and influenced initiatives at Centers for Medicare & Medicaid Services and Joint Commission on Accreditation of Healthcare Organizations; landmark work on healthcare quality paralleled efforts by Avedis Donabedian-influenced scholars at Johns Hopkins Bloomberg School of Public Health. Reports on vaccine safety and preparedness informed programs by the Centers for Disease Control and Prevention and responses to events such as the 2001 anthrax attacks and the 2009 H1N1 influenza pandemic. Studies on aging echoed research agendas at the Alzheimer's Association and National Institute on Aging, while analyses of health disparities intersected with advocacy by NAACP and policy work by the Robert Wood Johnson Foundation.

Membership and election

Membership comprised elected professionals drawn from medicine, public health, and biomedical research, including fellows associated with National Academy of Sciences, American Academy of Arts and Sciences, and recipients of awards like the Lasker Award and Nobel Prize in Physiology or Medicine. Election procedures mirrored practices used by the National Academies, with nominations vetted by committees containing scholars from Yale School of Medicine, Perelman School of Medicine at the University of Pennsylvania, and UCLA David Geffen School of Medicine. Membership conferred recognition akin to election to bodies such as the Institute of Electrical and Electronics Engineers and the American Philosophical Society for distinguished contributions.

Criticism and controversies

The institute faced criticism over perceived conflicts of interest when industry-funded studies and corporate grants from entities like Pfizer and GlaxoSmithKline supported projects, generating scrutiny similar to debates involving the World Health Organization and pharmaceutical regulation at the Food and Drug Administration. Critics from advocacy groups such as Public Citizen and scholars at Harvard School of Public Health questioned transparency and the influence of funders on recommendations about pharmaceuticals, vaccination policy, and clinical guidelines. Controversies also arose around methodological choices in reviews, paralleling disputes seen in panels convened by the Cochrane Collaboration and litigation involving health policy outcomes in the United States Court of Appeals.

Transition to National Academy of Medicine

In 2015 the Institute of Medicine was reconstituted and renamed the National Academy of Medicine as part of a governance update within the National Academies of Sciences, Engineering, and Medicine, a change announced by leaders including Ralph Cicerone and implemented during the tenure of presidents linked to National Academy of Sciences leadership. The transition aligned the institute with international counterparts such as the Academy of Medical Sciences (UK) and institutional partners like the Wellcome Trust and aimed to strengthen ties with global health actors including the World Health Organization and the Gavi, the Vaccine Alliance.

Category:Medical organizations based in the United States